SCHEMBL6889181

SCHEMBL6889181

CCN(CC)c1c(OC(C)C)c(=O)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7418982 0.85
SCHEMBL734610 0.72 ALDH1A3 (0.32)
SCHEMBL14164413 0.67 ALDH1A1 (0.33)
SCHEMBL2211653 0.67
SCHEMBL1057083 0.64
SCHEMBL15468476 0.64 ICAM1 (0.30)
SCHEMBL2210513 0.63
SCHEMBL22331762 0.63 SLC29A1 (0.34)
SCHEMBL16803983 0.63 ABCB1 (0.31)
SCHEMBL737196 0.63 ABCB1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244611-B1 SQUARIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS CELLTECH R&D LTD (GB) 2004-06-30 EP disclosed
EP-1244611-A1 SQUARIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS Celltech R&amp;D Limited (GB) 2002-10-02 EP disclosed
US-6455539-B2 AUTOIMMUNE DISEASE; ANTIINFLAMMATORY AGENTS; ANTIPROLIFERATORY AGENTS CELLTECH R&D LIMITED (GB) 2002-09-24 US disclosed
US-20010020017-A1 Squaric acid derivatives CELLTECH R&D LIMITED (GB) 2001-09-06 US disclosed
WO-2001047867-A1 SQUARIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS CELLTECH R & D LIMITED (GB) 2001-07-05 WO disclosed